LP
LEGN icon

LMR Partners’s Legend Biotech LEGN Stock Holding History

LMR Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,000
Closed -$978K – 1638
2025
Q3 		$978K Buy
+30,000
New +$1.11M ﹤0.01% 942
2024
Q2 		– Sell
-20,000
Closed -$1.12M – 1211
2024
Q1 		$1.12M Sell
20,000
-5,000
-20% -$302K 0.01% 654
2023
Q4 		$1.5M Buy
+25,000
New +$1.58M 0.02% 518

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

LMR Partners's LEGN Position: Q2 2026 in Review

LMR Partners reduced its Legend Biotech (LEGN) stake by 43% in Q2 2026, selling an estimated $405K and leaving 20,000 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

LMR Partners first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.06M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • LMR Partners held 20,000 shares of Legend Biotech worth $578K as of Q2 2026.
  • LMR Partners sold 15,000 Legend Biotech shares in Q2 2026, an estimated $405K.
  • Legend Biotech made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1151 holding.
  • LMR Partners first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
  • LMR Partners's Legend Biotech position peaked at $6.06M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.